Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · NCT03510442
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 0 mo–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 1
- Study start
- May 21, 2018
- Record last updated
- October 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Background
Inflammatory conditions can cause symptoms like fevers, arthritis, and rash. Systemic juvenile idiopathic arthritis (sJIA) is one of these conditions. So is adult-onset Still s disease (AOSD). Their causes are unknown. Researchers want to learn more about these conditions. This includes genetic changes and environmental factors.
Objective
To study sJIA and AOSD in children and adults over time.
Eligibility
People with known or suspected sJIA, AOSD, or similar inflammatory condition
Design
Participants will be screened with a phone call.
Participants will have 1 visit. It may be outpatient or they may be admitted to the clinic. The visit may last up to 5 days. Participants will have:
- Medical history
- Physical exam
- Musculoskeletal exam
- Questions about overall health and quality of life, disease activity, functional status, and cognitive ability.
Participants may also have
- Pictures taken of their skin, joints, or spine
- Blood, urine, and stool tests
- Scans or X-rays of joints with arthritis
- Chest X-ray
- Heart tests
- Skin biopsy. The skin will be numbed. The top layers of a small area will be scraped off.
Participants who have a joint aspiration may provide a fluid sample. The joint will be prepared, then fluid is removed by needle. A corticosteroid may be injected.
Participants who have a bone marrow biopsy may provide sample cells.
Participants may be seen by NIH specialists.
Members of the participant s family and healthy volunteers may give blood or saliva samples for genetic testing.
Participants may repeat some study tests every 6 months.
Conditions: Still's Disease, Adult-Onset; Systemic Inflammation; Arthritis; Autoinflammatory Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
- INCLUSION CRITERIA:
Affected subject
- Patients with signs and symptoms of sJIA will be classified as outlined in Diagnosis/Classification Criteria.
- Patients less than 16 years of age will be considered to have sJIA if they meet the ILAR criteria for sJIA.
- Patients 16 years of age and older will be considered to have sJIA if they have previously met ILAR criteria for sJIA.
- Patients with signs and symptoms of AOSD will be classified as outlined in Yamaguchi Criteria for diagnosing Adult-Onset Still's Disease.
- Patients 16 years of age and older will be considered to have AOSD if they meet the Yamaguchi criteria for AOSD (including a negative ANA and RF).
- Patients may be considered to have a diagnosis of AOSD if they met criteria for diagnosis in the past but do not still have present evidence of disease.
- Pregnant people with still's disease are allowed to enroll. Pregnant people will not be asked to submit to a skin biopsy or bone marrow aspiration.
- The minimum age for participation in this study is between 0 and older.
Healthy Subjects
- Healthy Volunteers related to individuals included under items 1 and 2 above will be enrolled.
- Unrelated healthy volunteers will be enrolled for clinical, cellular, molecular, and biochemical assays, and genetic evaluation. Individuals who undergo phlebotomy specifically to provide a control specimen will include both pediatric and adult patients and will not be pregnant.
- Healthy Volunteer should not have any history of autoimmune, autoinflammatory, rheumatic or proliferative/malignant disease or any unexplained inflammatory signs/symptoms or conditions (applies to unrelated).
- The minimum age for participation in this study under this cohort is 2 years.
EXCLUSION CRITERIA
Affected and Healthy subjects
- In adults, inability, or the lack of capacity to provide informed consent. In the case of minors, unavailability of a parent or guardian.
- Presence of any medical condition that would, in the opinion of the investigators, confuse the interpretation of the study.
- Unavailability, or inability to adhere with the schedule for follow-up visits
Recruiting US locations
National Institutes of Health Clinical Center
Bethesda, MD 20892
Site contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) · 800-411-1222 · prpl@cc.nih.gov
Study contacts (from the official record)
- Michelle R Millwood · (301) 827-1849 · millwoodmr@mail.nih.gov
- Michael J Ombrello, M.D. · (301) 435-4037 · ombrellomj@mail.nih.gov
Similar studies in Maryland
All arthritis studies in Maryland →- RecruitingPhase 2
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Merck Sharp & Dohme LLC
- Location
- Baltimore, MD + 35 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With…
Amgen
- Location
- Columbia, MD + 73 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Takeda
- Location
- Hagerstown, MD + 45 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
AstraZeneca
- Location
- Baltimore, MD + 20 other US sites
- Eligibility basics
- Ages 18+